Physician

Kai Mcgreevy, M.D

According to 2025 Medicare claims, Kai Mcgreevy, M.D (NPI: 1922208610) practices neurology in the Deltona-Daytona Beach-Ormond Beach, FL market, with the plurality of this provider's patient population coming from Flagler, FL. This provider's primary affiliated billing organization is ESTATE VENTURES, LLC (NPI: 1033505706; TIN: 472927698) and primary practice location at 32095-8805.

Mcgreevy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 797 traditional Medicare patients, billed 73,552 HCPCS/CPT codes, and received $1,994,859 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,251 prescription claims across 696 beneficiaries totaling $360,010 in drug costs, led by Nurtec Odt (Rimegepant Sulfate). DME data shows 20 claims. Open Payments data shows 97 records totaling $3,131. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $433,159 to $1,994,859. Similarly, Part D prescription costs have risen steadily, from $26,967 to $360,010. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $511 to $1,819.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	351	34,087	$433,159
2016	314	64,459	$648,511
2017	312	71,924	$757,056
2018	467	121,056	$1,492,643
2019	501	129,272	$1,646,877
2020	354	79,518	$1,059,437
2021	390	74,094	$1,215,301
2022	502	80,785	$1,330,388
2023	669	61,665	$1,465,429
2024	797	73,552	$1,994,859

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	189	750	$26,967
2016	138	824	$25,409
2017	219	1,458	$56,644
2018	339	2,528	$116,919
2019	372	2,962	$105,172
2020	271	2,569	$71,881
2021	300	3,034	$139,538
2022	434	4,230	$221,073
2023	576	5,154	$285,976
2024	696	5,251	$360,010

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	36	36	$19,842
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	15	$894
2021	N/R	15	$1,083
2022	N/R	19	$1,512
2023	N/R	N/R	N/R
2024	N/R	20	$1,756

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	616	2,889	$99
96130	Evaluation of psychological test, first hour	728	2,138	$95
J3300	Injection, triamcinolone acetonide, preservative free, 1 mg	362	39,844	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	366	646	$8
83735	Magnesium level	360	637	$7

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Nurtec Odt	Rimegepant Sulfate	27	750	$36,772
Ubrelvy	Ubrogepant	20	615	$31,267
Botox	Onabotulinumtoxina	19	1,656	$24,992
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	684	19,989	$19,014
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	392	11,594	$14,004

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	20	$1,756

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	97	$3,131	Spinal Simplicity, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kai Mcgreevy, M.D?

Tedicare shows public-source Medicare data for Kai Mcgreevy, M.D (NPI 1922208610), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kai Mcgreevy, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kai Mcgreevy, M.D?

Kai Mcgreevy, M.D is linked to ESTATE VENTURES, LLC (billing NPI 1033505706) in the available physician profile data.

Does Kai Mcgreevy, M.D have Open Payments data?

Kai Mcgreevy, M.D has 97 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.